vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Hillenbrand, Inc. (HI). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $550.2M, roughly 1.7× Hillenbrand, Inc.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -0.4%, a 8.1% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -22.2%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $-31.6M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -16.3%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Hillenbrand, Inc. is a global diversified industrial firm that designs, manufactures, and distributes specialized processing equipment and durable industrial solutions. It serves food & beverage, agriculture, manufacturing, waste management sectors, with operations across North America, Europe, and APAC.
ATR vs HI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $550.2M |
| Net Profit | $74.3M | $-2.2M |
| Gross Margin | — | 33.4% |
| Operating Margin | 11.0% | -2.2% |
| Net Margin | 7.7% | -0.4% |
| Revenue YoY | 13.5% | -22.2% |
| Net Profit YoY | -26.4% | -134.4% |
| EPS (diluted) | $1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $550.2M | ||
| Q3 25 | $961.1M | $652.1M | ||
| Q2 25 | $966.0M | $598.9M | ||
| Q1 25 | $887.3M | $715.9M | ||
| Q4 24 | $848.1M | $706.9M | ||
| Q3 24 | $909.3M | $837.6M | ||
| Q2 24 | $910.1M | $786.6M | ||
| Q1 24 | $915.4M | $785.3M |
| Q4 25 | $74.3M | $-2.2M | ||
| Q3 25 | $127.9M | $75.7M | ||
| Q2 25 | $111.7M | $1.9M | ||
| Q1 25 | $78.8M | $-40.9M | ||
| Q4 24 | $100.9M | $6.4M | ||
| Q3 24 | $100.0M | $14.6M | ||
| Q2 24 | $90.5M | $-248.9M | ||
| Q1 24 | $83.1M | $6.1M |
| Q4 25 | — | 33.4% | ||
| Q3 25 | — | 34.8% | ||
| Q2 25 | — | 33.8% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 33.2% | ||
| Q3 24 | — | 34.4% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | 11.0% | -2.2% | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | 1.8% | ||
| Q1 25 | 12.8% | -6.2% | ||
| Q4 24 | 14.2% | 2.2% | ||
| Q3 24 | 15.2% | — | ||
| Q2 24 | 13.8% | -32.7% | ||
| Q1 24 | 12.2% | 1.6% |
| Q4 25 | 7.7% | -0.4% | ||
| Q3 25 | 13.3% | 11.6% | ||
| Q2 25 | 11.6% | 0.3% | ||
| Q1 25 | 8.9% | -5.7% | ||
| Q4 24 | 11.9% | 0.9% | ||
| Q3 24 | 11.0% | 1.7% | ||
| Q2 24 | 9.9% | -31.6% | ||
| Q1 24 | 9.1% | 0.8% |
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | $1.07 | ||
| Q2 25 | $1.67 | $0.03 | ||
| Q1 25 | $1.17 | $-0.58 | ||
| Q4 24 | $1.48 | $0.09 | ||
| Q3 24 | $1.48 | $0.20 | ||
| Q2 24 | $1.34 | $-3.53 | ||
| Q1 24 | $1.23 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $173.1M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $1.4B |
| Total Assets | $5.3B | $4.5B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $173.1M | ||
| Q3 25 | $264.8M | $164.8M | ||
| Q2 25 | $169.8M | $162.8M | ||
| Q1 25 | $136.8M | $458.4M | ||
| Q4 24 | $226.2M | $208.0M | ||
| Q3 24 | $327.9M | $199.3M | ||
| Q2 24 | $223.9M | $223.8M | ||
| Q1 24 | $201.1M | $224.4M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | $1.5B | ||
| Q2 25 | $535.1M | $1.7B | ||
| Q1 25 | $561.2M | $1.9B | ||
| Q4 24 | $688.1M | $1.9B | ||
| Q3 24 | $822.7M | $1.9B | ||
| Q2 24 | $681.5M | $2.1B | ||
| Q1 24 | $680.4M | $2.1B |
| Q4 25 | $2.7B | $1.4B | ||
| Q3 25 | $2.8B | $1.4B | ||
| Q2 25 | $2.7B | $1.3B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $1.4B | ||
| Q2 24 | $2.4B | $1.4B | ||
| Q1 24 | $2.3B | $1.7B |
| Q4 25 | $5.3B | $4.5B | ||
| Q3 25 | $5.1B | $4.5B | ||
| Q2 25 | $4.9B | $4.7B | ||
| Q1 25 | $4.5B | $4.8B | ||
| Q4 24 | $4.4B | $5.1B | ||
| Q3 24 | $4.6B | $5.2B | ||
| Q2 24 | $4.5B | $5.3B | ||
| Q1 24 | $4.4B | $5.6B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | 1.10× | ||
| Q2 25 | 0.20× | 1.27× | ||
| Q1 25 | 0.22× | 1.44× | ||
| Q4 24 | 0.28× | 1.38× | ||
| Q3 24 | 0.32× | 1.33× | ||
| Q2 24 | 0.28× | 1.48× | ||
| Q1 24 | 0.29× | 1.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $-27.4M |
| Free Cash FlowOCF − Capex | $96.9M | $-31.6M |
| FCF MarginFCF / Revenue | 10.1% | -5.7% |
| Capex IntensityCapex / Revenue | 9.0% | 0.8% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $7.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $-27.4M | ||
| Q3 25 | $177.6M | $67.7M | ||
| Q2 25 | $126.0M | $-1.5M | ||
| Q1 25 | $82.7M | $1.3M | ||
| Q4 24 | $178.2M | $-11.3M | ||
| Q3 24 | $229.3M | $166.5M | ||
| Q2 24 | $143.6M | $45.6M | ||
| Q1 24 | $92.3M | $3.2M |
| Q4 25 | $96.9M | $-31.6M | ||
| Q3 25 | $114.3M | $58.6M | ||
| Q2 25 | $62.5M | $-11.2M | ||
| Q1 25 | $25.9M | $-8.0M | ||
| Q4 24 | $112.2M | $-21.5M | ||
| Q3 24 | $162.7M | $153.4M | ||
| Q2 24 | $75.4M | $29.7M | ||
| Q1 24 | $16.7M | $-9.6M |
| Q4 25 | 10.1% | -5.7% | ||
| Q3 25 | 11.9% | 9.0% | ||
| Q2 25 | 6.5% | -1.9% | ||
| Q1 25 | 2.9% | -1.1% | ||
| Q4 24 | 13.2% | -3.0% | ||
| Q3 24 | 17.9% | 18.3% | ||
| Q2 24 | 8.3% | 3.8% | ||
| Q1 24 | 1.8% | -1.2% |
| Q4 25 | 9.0% | 0.8% | ||
| Q3 25 | 6.6% | 1.4% | ||
| Q2 25 | 6.6% | 1.6% | ||
| Q1 25 | 6.4% | 1.3% | ||
| Q4 24 | 7.8% | 1.4% | ||
| Q3 24 | 7.3% | 1.6% | ||
| Q2 24 | 7.5% | 2.0% | ||
| Q1 24 | 8.3% | 1.6% |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | 0.89× | ||
| Q2 25 | 1.13× | -0.79× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | -1.77× | ||
| Q3 24 | 2.29× | 11.40× | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | 0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
HI
| Transferred At Point In Time | $256.5M | 47% |
| Transferred Over Time | $207.1M | 38% |
| Molding Technology Solutions | $86.6M | 16% |
